{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:04:27Z","timestamp":1766232267328,"version":"3.48.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK111024"],"award-info":[{"award-number":["P30DK111024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdiacomp.2025.109207","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:19:57Z","timestamp":1761265197000},"page":"109207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data-driven subtypes of newly diagnosed youth-onset type 2 diabetes in the USA"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3907-0555","authenticated-orcid":false,"given":"Jiali","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo M.","family":"Carrillo-Larco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed K.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jithin Sam","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109207_bb0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/dci22-0046","article-title":"Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic","volume":"46","author":"Perng","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0015","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/dci18-0052","article-title":"Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association","volume":"41","author":"Arslanian","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0020","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(17)32461-3","article-title":"Type 2 diabetes in youth is a disease of poverty","volume":"390","author":"McGavock","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-med-042120-012033","article-title":"Spectrum of phenotypes and causes of type 2 diabetes in children","volume":"73","author":"Shah","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0030","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2337\/dc18-0243","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test","volume":"41","author":"RISE Consortium","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0035","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"TODAY Study Group","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0040","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e328357a797","article-title":"Diabetic neuropathy: one disease or two?","volume":"25","author":"Callaghan","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0055","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/dc14-0574","article-title":"The SEARCH for Diabetes in Youth Study: rationale, findings, and future directions","volume":"37","author":"Hamman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0060","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2337\/dc10-2324","article-title":"Etiological approach to characterization of diabetes type","volume":"34","author":"Dabelea","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0065","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dc21-0027","article-title":"Baseline predictors of glycemic worsening in youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes in the Restoring Insulin Secretion (RISE) study","volume":"44","author":"Sam","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41581-022-00645-1","article-title":"Youth-onset type 2 diabetes mellitus: an urgent challenge","volume":"19","author":"Bjornstad","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0080","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/clinem\/dgab762","article-title":"Prevalence trends of diabetes subgroups in the United States: a data-driven analysis spanning three decades from NHANES (1988-2018)","volume":"107","author":"Antonio-Villa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0090","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0140-6736(17)31371-5","article-title":"Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden","volume":"389","author":"Viner","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0095","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1093\/hmg\/ddy114","article-title":"The next generation of precision medicine: observational studies, electronic health records, biobanks and continuous monitoring","volume":"27","author":"Glicksberg","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0100","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41591-023-02502-5","article-title":"Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine","volume":"29","author":"Tobias","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001549","article-title":"Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9","volume":"8","author":"Bonora","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s42255-023-00943-3","article-title":"Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology","volume":"6","author":"Dwibedi","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-5448.2007.00237.x","article-title":"Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes","volume":"8","author":"TODAY Study Group","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0120","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000511362","article-title":"The association between antidiabetic agents and leukocyte telomere length in the novel classification of type 2 diabetes mellitus","volume":"67","author":"Huang","year":"2021","journal-title":"Gerontology"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0135","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00125-021-05485-5","article-title":"Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study","volume":"64","author":"Lugner","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12859-022-04675-1","article-title":"Statistical power for cluster analysis","volume":"23","author":"Dalmaijer","year":"2022","journal-title":"BMC Bioinformatics"},{"author":"CDC","key":"10.1016\/j.jdiacomp.2025.109207_bb0145"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0155","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0165","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1080\/02664763.2019.1701638","article-title":"Residualization: justification, properties and application","volume":"47","author":"Garc\u00eda","year":"2020","journal-title":"J Appl Stat"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0170","series-title":"2011 31st International Conference on Distributed Computing Systems Workshops","first-page":"166","article-title":"Finding a \u201cKneedle\u201d in a haystack: detecting knee points in system behavior","author":"Satopaa","year":"2011"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0185","article-title":"A machine learning-based classification of adult-onset diabetes identifies patients at risk of liver-related complications","volume":"5","author":"Otero Sanchez","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0190","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.00130.2014","article-title":"Physiological effects and therapeutic potential of proinsulin C-peptide","volume":"307","author":"Yosten","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6955723","article-title":"Clinical characterization of data-driven diabetes clusters of pediatric type 2 diabetes","volume":"2023","author":"Abbasi","year":"2023","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S2213-8587(23)00195-X","article-title":"Achieving replicable subphenotypes of adult-onset diabetes","volume":"11","author":"Varghese","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0205","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0210","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-8587(25)00120-2","article-title":"Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study","volume":"13","author":"Katte","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/jpem-2019-0310","volume":"33","author":"\u00c7in","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8586167","article-title":"TG: HDL-C ratio is a good marker to identify children affected by obesity with increased cardiometabolic risk and insulin resistance","volume":"2019","author":"Nur Zati Iwani","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","article-title":"Glucose control and diabetic neuropathy: lessons from recent large clinical trials","volume":"14","author":"Ang","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0240","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.2147\/DMSO.S491560","article-title":"Relationship between fasting C-peptide to diabetes duration ratio (FCP\/DD) and diabetic peripheral neuropathy","volume":"17","author":"Fu","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0245","article-title":"The role of C-peptide in diabetes and its complications: an updated review","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0250","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/dc16-1690","article-title":"Relationships between type 2 diabetes, neuropathy, and microvascular dysfunction: evidence from patients with cryptogenic axonal polyneuropathy","volume":"40","author":"Emanuel","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/pedi.13153","article-title":"Diabetic neuropathy in children and youth: new and emerging risk factors","volume":"22","author":"Akinci","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109207_bb0260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/gim.2017.150","article-title":"Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial","volume":"20","author":"Kleinberger","year":"2018","journal-title":"Genet Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:01:36Z","timestamp":1766232096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725002600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1056872725002600"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109207","relation":{},"ISSN":["1056-8727"],"issn-type":[{"type":"print","value":"1056-8727"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data-driven subtypes of newly diagnosed youth-onset type 2 diabetes in the USA","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109207"}}